| mRNA |
PX-12 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-09 |
| mRNA |
decitabine:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
3e-07 |
| mRNA |
STF-31 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
5e-07 |
| mRNA |
PL-DI |
CTRPv2 |
pan-cancer |
AAC |
0.17 |
9e-07 |
| mRNA |
pac-1 |
CTRPv2 |
pan-cancer |
AAC |
0.2 |
9e-07 |
| mRNA |
selumetinib:PLX-4032 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.19 |
1e-06 |
| mRNA |
ABT-263 |
CTRPv2 |
pan-cancer |
AAC |
0.19 |
1e-06 |
| mRNA |
CCT036477 |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
1e-06 |
| mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.18 |
2e-06 |
| mRNA |
GSK1070916 |
GDSC1000 |
pan-cancer |
AAC |
0.16 |
3e-06 |